STARD1 INHIBITORS FOR THE TREATMENT OF LYSOSOMAL DISORDERS
The invention relates to peptides for use in the treatment and/or diagnostic of lysosomal storage diseases, specifically peptides or proteins that inhibit STARD1 expression levels and subsequently mitochondrial cholesterol levels, and their use in the treatment of lysosomal storage diseases.
Gespeichert in:
Hauptverfasser: | , , , , |
---|---|
Format: | Patent |
Sprache: | eng ; fre ; ger |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | The invention relates to peptides for use in the treatment and/or diagnostic of lysosomal storage diseases, specifically peptides or proteins that inhibit STARD1 expression levels and subsequently mitochondrial cholesterol levels, and their use in the treatment of lysosomal storage diseases. |
---|